Human Centriole and Centrosome Antibody IgG ELISA Kit |
MBS039049-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human IgG antibody Laboratories manufactures the mln2480/tak580 medchemexpress reagents distributed by Genprice. The Mln2480/Tak580 Medchemexpress reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Mln2480/Tak580 products are available in stock. Specificity: Mln2480/Tak580 Category: Medchemexpress
Human True Insulin ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human True Insulin ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human True Insulin GENLISA ELISA |
Krishgen |
1 x 96 wells |
EUR 286 |
Human True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human True insulin ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
48 wells plate |
EUR 280 |
Chemicals information
(R)-MLN-4760 |
HY-19414A |
MedChemExpress |
10 mg |
EUR 2121.25 |
Description: (R)-MLN-4760, the R-enantiomer of MLN-4760, is an ACE2 inhibitor, with an IC50 of 8.4 μM. (R)-MLN-4760 is the less active isomer[1]. |
MLN3126 |
HY-123763 |
MedChemExpress |
10 mg |
EUR 1461.06 |
Description: MLN3126 is an orally active and potent CCR9 antagonist. MLN3126 inhibits CCL25-induced calcium mobilization and chemotaxis of mouse primary thymocytes, wiht an IC50 value of 6.3 nM for calcium influx[1]. |
MLN120B |
HY-15473 |
MedChemExpress |
50mg |
EUR 779.23 |
Description: MLN120B (ML120B) is a potent, ATP competitive, and orally active inhibitor of IKKβ with an IC50 of 60 nM. MLN120B inhibits multiple myeloma cell growth in vitro and in vivo and also can be used for the research of rheumatoid arthritis[1][2]. |
MLN120B (dihydrochloride) |
HY-15473A |
MedChemExpress |
10 mg |
EUR 779.23 |
Description: MLN120B dihydrochloride (ML120B dihydrochloride) is a potent, ATP competitive, and orally active inhibitor of IKKβ with an IC50 of 60 nM. MLN120B inhibits multiple myeloma cell growth in vitro and in vivo and also can be used for the research of rheumatoid arthritis[1][2]. |
TAK-220 |
HY-19974 |
MedChemExpress |
5mg |
EUR 1948.08 |
Description: TAK-220 is a selective and orally bioavailable CCR5 antagonist, with IC50s of 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively, but shows no effect on the binding to CCR1, CCR2b, CCR3, CCR4, or CCR7; TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1 HTN), and 0.55 nM (HIV-1 HHA), and EC90s of 12 nM (HIV-1 KK), 5 nM (HIV-1 CTV), 12 nM (HIV-1 HKW), 28 nM (HIV-1 HNK), 15 nM (HIV-1 HTN), and 4 nM (HIV-1 HHA) in PBMCs. |
TAK-960 |
HY-15160 |
MedChemExpress |
100mg |
EUR 771.66 |
Description: TAK-960 is an orally available, selective inhibitor of polo-like kinase 1 (PLK1), with an IC50 of 0.8 nM. TAK-960 also shows inhibitory activities against PLK2 and PLK3, with IC50s of 16.9 and 50.2 nM, respectively. TAK-960 inhibits proliferation of multiple cancer cell lines and exhibits significant efficacy against multiple tumor xenografts[1]. |
TAK-285 |
HY-15196 |
MedChemExpress |
50mg |
EUR 487.02 |
Description: TAK-285 is a potent, selective, ATP-competitive and orally active HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, respectively. TAK-285 is >10-fold selectivity for HER1/2 than HER4, and less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. TAK-285 has effective antitumor activity[1]. TAK-285 can cross the blood-brain barrier (BBB)[2]. |
TAK-778 |
HY-100167 |
MedChemExpress |
5mg |
EUR 3370.8 |
Description: TAK-778 is a derivative of ipriflavone and has been shown to induce bone growth in in vitro and in vivo models. |
TAK-024 |
HY-100254 |
MedChemExpress |
10mg |
EUR 5359.2 |
Description: TAK-024 is a platelet inhibitor with IC50s of 31, 79 and 51 nM in human, monkey and guinea pig, respectively. |
TAK-243 |
HY-100487 |
MedChemExpress |
10mg |
EUR 630.96 |
Description: TAK-243 (MLN7243) is a first-in-class, selective ubiquitin activating enzyme, UAE (UBA1) inhibitor (IC50=1 nM), which blocks ubiquitin conjugation, disrupting monoubiquitin signaling as well as global protein ubiquitination. TAK-243 (MLN7243) induces endoplasmic reticulum (ER) stress, abrogates NF-κB pathway activation and promotes apoptosis[1][2]. |
TAK-659 |
HY-100867 |
MedChemExpress |
50mg |
EUR 872.4 |
Description: TAK-659 is a highly potent, selective, reversible and orally available dual inhibitor of spleen tyrosine kinase (SYK) and fms related tyrosine kinase 3 (FLT3), with an IC50 of 3.2 nM and 4.6 nM for SYK and FLT3, respectively. TAK-659 induces cell death in tumor cells but not in nontumor cells, and with potential for the treatment of chronic lymphocytic leukemia (CLL)[1][2][3][4]. |
TAK-915 |
HY-103493 |
MedChemExpress |
10 mg |
EUR 4502.23 |
Description: TAK-915 is a potent, selective, brain-penetrant and orally active phosphodiesterase 2A (PDE2A) inhibitor with an IC50 of 0.61 nM. TAK-915 is >4100-fold more selectivity for PDE2A than PDE1A. TAK-915 has the potential for neuropsychiatric and neurodegenerative disorders treatment[1][2]. |
TAK-715 |
HY-10456 |
MedChemExpress |
50mg |
EUR 471.87 |
Description: TAK-715 is an orally active and potent p38 MAPK inhibitor with IC50s of 7.1 nM, 200 nM for p38α and p38β, respectively. TAK-715 inhibits casein kinase I (CK1δ/ε) to regulate activation of Wnt/β-catenin signaling. TAK-715 shows good significant efficacy in a rat arthritis model[1][2]. |
TAK-593 |
HY-15506 |
MedChemExpress |
50mg |
EUR 800.88 |
Description: TAK-593 is a potent VEGFR and PDGFR family inhibitor with IC50s of 3.2, 0.95, 1.1, 4.3 and 13 nM for VEGFR1, VEGFR2, VEGFR3, PDFGRα and PDFGRβ, respectively. |
TAK-632 |
HY-15767 |
MedChemExpress |
25mg |
EUR 178.57 |
Description: TAK-632 is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAFV600E, BRAFWT, respectively. |
TAK-441 |
HY-16475 |
MedChemExpress |
10 mg |
EUR 2272.76 |
Description: TAK-441 is a highly potent and orally active hedgehog (Hh) signaling inhibitor with an IC50value of 4.4 nM. TAK-441 has strong antitumor activity in solid tumors[1][2][3]. |